PLAIN ENGLISH GROWTH CAPITAL LOAN AND SECURITY AGREEMENTLoan and Security Agreement • March 19th, 2008 • Bayhill Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledMarch 19th, 2008 Company IndustryThis is a PLAIN ENGLISH GROWTH CAPITAL LOAN AND SECURITY AGREEMENT dated as of March 7, 2007 by and between BAYHILL THERAPEUTICS, INC., a Delaware corporation, and TRIPLEPOINT CAPITAL LLC, a Delaware company. The words “We”, “Us”, or “Our” refer to the Lender, which is TRIPLEPOINT CAPITAL LLC.
Renault & Handley INDUSTRIAL & COMMERCIAL REAL ESTATE This Lease is dated, for reference purposes only, the 23rd day of November 2004, and is by and between PARTIES Renault & Handley Employees Investment Co. and Bayhill Therapeutics, Inc. hereinafter...Bayhill Therapeutics, Inc. • March 19th, 2008 • Pharmaceutical preparations
Company FiledMarch 19th, 2008 Industry* The Registrant is re-filing Exhibit 10.6 to the Registrant’s Form S-1 originally filed on January 9, 2008 to include all exhibits, schedules and appendices to this agreement. The Registrant has made no other changes to the previously filed agreement.
EMPLOYMENT AGREEMENTEmployment Agreement • March 19th, 2008 • Bayhill Therapeutics, Inc. • Pharmaceutical preparations • California
Contract Type FiledMarch 19th, 2008 Company Industry JurisdictionThis Employment Agreement is made and entered into by and between Tolerion, Inc. (the “Company”) and Hideki Garren (the “Employee”), as of April 16, 2002.
ContractBayhill Therapeutics, Inc. • March 19th, 2008 • Pharmaceutical preparations • California
Company FiledMarch 19th, 2008 Industry JurisdictionTHIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED OR ANY STATE SECURITIES LAWS. NO SALE OR DISPOSITION MAY BE EFFECTED WITHOUT (i) EFFECTIVE REGISTRATION STATEMENTS RELATED THERETO, (ii) AN OPINION OF COUNSEL OR OTHER EVIDENCE, REASONABLY SATISFACTORY TO THE COMPANY, THAT SUCH REGISTRATIONS ARE NOT REQUIRED, (iii) RECEIPT OF NO-ACTION LETTERS FROM THE APPROPRIATE GOVERNMENTAL AUTHORITIES, OR (iv) OTHERWISE COMPLYING WITH THE PROVISIONS OF SECTION 7 OF THIS WARRANT.